News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
354,082 Results
Type
Article (21636)
Company Profile (138)
Press Release (332294)
Multimedia
Podcasts (129)
Webinars (20)
Section
Business (106778)
Career Advice (901)
Deals (18942)
Drug Delivery (126)
Drug Development (51476)
Employer Resources (80)
FDA (7960)
Job Trends (7875)
News (188580)
Policy (17603)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (760)
Accelerated approval (34)
Adcomms (25)
Allergies (112)
Alliances (28165)
ALS (114)
Alzheimer's disease (872)
Antibody-drug conjugate (ADC) (307)
Approvals (8247)
Artificial intelligence (370)
Autoimmune disease (168)
Automation (24)
Bankruptcy (181)
Best Places to Work (5563)
BIOSECURE Act (14)
Biosimilars (206)
Biotechnology (60)
Bladder cancer (91)
Brain cancer (44)
Breast cancer (328)
Cancer (2919)
Cardiovascular disease (304)
Career advice (756)
Career pathing (30)
CAR-T (132)
CDC (21)
Cell therapy (360)
Cervical cancer (21)
Clinical research (46034)
Collaboration (1281)
Company closure (2)
Compensation (457)
Complete response letters (70)
COVID-19 (1182)
CRISPR (61)
C-suite (762)
Cystic fibrosis (95)
Data (4438)
Decentralized trials (3)
Denatured (30)
Depression (101)
Dermatology (50)
Diabetes (305)
Diagnostics (2017)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (22)
Drug discovery (235)
Drug pricing (217)
Drug shortages (36)
Duchenne muscular dystrophy (174)
Earnings (42279)
Editorial (54)
Employer branding (10)
Employer resources (79)
Events (52589)
Executive appointments (709)
FDA (9945)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (10)
Funding (838)
Gene editing (110)
Generative AI (43)
Gene therapy (326)
GLP-1 (914)
Government (2085)
Grass and pollen (5)
Guidances (223)
Healthcare (6096)
HIV (42)
Huntington's disease (31)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (81)
Immunology and inflammation (210)
Immuno-oncology (58)
Indications (134)
Infectious disease (1372)
Inflammatory bowel disease (145)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (163)
Interviews (122)
IPO (7560)
IRA (54)
Job creations (2453)
Job search strategy (656)
JPM (55)
Kidney cancer (14)
Labor market (77)
Layoffs (359)
Leadership (35)
Legal (4174)
Liver cancer (40)
Longevity (13)
Lung cancer (415)
Lymphoma (247)
Machine learning (23)
Management (31)
Manufacturing (712)
MASH (135)
Medical device (2077)
Medtech (2095)
Mergers & acquisitions (11991)
Metabolic disorders (1091)
mRNA (109)
Multiple sclerosis (126)
NASH (21)
Neurodegenerative disease (215)
Neuropsychiatric disorders (90)
Neuroscience (1803)
Neurotech (1)
NextGen: Class of 2026 (2370)
Non-profit (923)
Now hiring (59)
Obesity (630)
Opinion (248)
Ovarian cancer (99)
Pain (183)
Pancreatic cancer (132)
Parkinson's disease (216)
Partnered (18)
Patents (344)
Patient recruitment (372)
Peanut (22)
People (35145)
Pharmaceutical (71)
Pharmacy benefit managers (37)
Phase 1 (14520)
Phase 2 (19446)
Phase 3 (15569)
Pipeline (5152)
Policy (261)
Postmarket research (1628)
Preclinical (5090)
Press Release (29)
Prostate cancer (168)
Psychedelics (35)
Radiopharmaceuticals (218)
Rare diseases (695)
Real estate (3226)
Recruiting (34)
Regulatory (14451)
Reports (27)
Research institute (852)
Resumes & cover letters (142)
Rett syndrome (11)
RNA editing (16)
RSV (50)
Schizophrenia (147)
Series A (162)
Series B (100)
Service/supplier (7)
Sickle cell disease (77)
Special edition (24)
Spinal muscular atrophy (126)
Sponsored (20)
Startups (2067)
State (2)
Stomach cancer (13)
Supply chain (94)
Tariffs (97)
The Weekly (96)
Vaccines (519)
Venture capital (89)
Weight loss (449)
Women's health (65)
Worklife (10)
Date
Today (75)
Last 7 days (376)
Last 30 days (1673)
Last 365 days (15309)
2026 (7169)
2025 (15572)
2024 (17812)
2023 (19786)
2022 (26073)
2021 (26980)
2020 (25077)
2019 (20212)
2018 (15682)
2017 (17394)
2016 (16335)
2015 (18906)
2014 (14899)
2013 (12693)
2012 (13601)
2011 (13918)
2010 (12858)
Location
Africa (425)
Alabama (48)
Alaska (1)
Arizona (103)
Arkansas (9)
Asia (26411)
Australia (3420)
California (5872)
Canada (2168)
China (983)
Colorado (242)
Connecticut (241)
Delaware (236)
Europe (55829)
Florida (1024)
Georgia (118)
Hawaii (2)
Idaho (20)
Illinois (560)
India (73)
Indiana (357)
Iowa (5)
Japan (429)
Kansas (90)
Kentucky (33)
Louisiana (9)
Maine (4)
Maryland (711)
Massachusetts (4680)
Michigan (76)
Minnesota (296)
Mississippi (3)
Missouri (48)
Montana (13)
Nebraska (15)
Nevada (41)
New Hampshire (11)
New Jersey (2245)
New Mexico (21)
New York (1605)
North Carolina (945)
North Dakota (2)
Northern California (2835)
Ohio (158)
Oklahoma (8)
Oregon (23)
Pennsylvania (1281)
Puerto Rico (26)
Rhode Island (29)
South America (619)
South Carolina (14)
South Dakota (1)
Southern California (2508)
Tennessee (80)
Texas (812)
United States (22061)
Utah (107)
Virginia (225)
Washington D.C. (60)
Washington State (467)
West Virginia (1)
Wisconsin (63)
Wyoming (1)
354,082 Results for "nordic pharma amring pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gaelic Labs gains BSI Kitemark™ Certification for Minimized Risk of AMR
Gaelic Laboratories, a GMP-approved manufacturer of Beta-Lactam antibiotics, has successfully obtained BSI Kitemark™ Certification for Minimized Risk of Antimicrobial Resistance (AMR), demonstrating a commitment to responsible manufacturing.
June 1, 2026
·
1 min read
Pharm Country
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life Sciences, B.V. to Nordic Group, B.V., a subsidiary of SEVER Life Sciences B.V., which occurred on June 1, 2023.
March 4, 2024
·
3 min read
Press Releases
MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS
April 9, 2026
·
5 min read
Business
Lilly is pharma’s top dog, placing first in innovation and invention: IDEA
Eli Lilly is the first pharma company to take first place in both categories in the eight years that intelligence firm IDEA Pharma has put out its analysis. Skyrocketing sales and multiple FDA approvals helped the company shoot to the top.
May 26, 2026
·
2 min read
·
Tristan Manalac
China
Big Pharma makes ‘creative effort’ to fold Chinese assets into pipelines
Recent deals from Pfizer and Bristol Myers Squibb hint at Big Pharma’s more collaborative approach to partnering with Chinese companies.
June 2, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Pharma manufacturing projected to create 19,000 jobs through 2034
The forecast makes pharma one of the fastest-growing manufacturing industries in the U.S.
June 3, 2026
·
2 min read
·
Nick Paul Taylor
Deals
Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States
Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today the completion of its acquisition of Visant Medical, Inc. (Visant), a leader in medical technology innovation in Dry Eye Disease (DED).
December 18, 2023
·
5 min read
Press Releases
Bavarian Nordic Launches Next Tranche of Share Buy-Back Program - June 2, 2026
June 2, 2026
·
3 min read
Press Releases
Bavarian Nordic Announces Interim Results for the First Three Months of 2026
May 13, 2026
·
6 min read
Press Releases
Bavarian Nordic – Completion of Share Buy-Back Program - May 11, 2026
May 11, 2026
·
2 min read
1 of 35,409
Next
